Form D · Biotechnology
SonoThera, Inc.
South San Francisco, CA · CIK 0001945154
Offering snapshot reported Jun 30, 2026 · SEC filing
- Reported sold
- $125M Offering amount: $125M
- Investors reported
- 22 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 8, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 30, 2026 | Initial | $125,450,218 | No comparison | 22 | SEC filing |
| Dec 29, 2022 | Initial | $30,375,000 | No comparison | 12 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06c
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0 (estimated)
- Finders' fees
- $0
- Form D file number
- 021-589036
Source: Form D, filed Jun 30, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael Davidson | Director, Executive |
| Rakhshita Dhar | Director |
| Steven Feinstein | Executive |
| Steven Gillis | Director |
| Kenneth Greenberg | Director, Executive |
| Brian Halak | Director |
| Lori Hu | Director |
| Rajul Jain | Director |
| Tom Willis | Director |
| Asish Xavier | Director |
| Carolyne Zimmerman | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
201 Haskins Way, 5 Th Floor
South San Francisco, CA, 94080
Phone: 510-414-2997
South San Francisco, CA, 94080
Phone: 510-414-2997